Oakland, CA, United States of America

Rachel Ellen Gerver

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rachel Ellen Gerver: Innovator in Biomedical Devices

Introduction

Rachel Ellen Gerver is a prominent inventor based in Oakland, CA. She has made significant contributions to the field of biomedical devices, holding 2 patents that showcase her innovative spirit and technical expertise. Her work focuses on developing advanced technologies that enhance medical diagnostics and treatment.

Latest Patents

Gerver's latest patents include an ingestible device and associated methods. This ingestible device is designed to produce spectral data of one or more analytes, along with methods for characterizing the gastrointestinal tract of a subject containing such analytes. Additionally, she has developed spectrally encoded microbeads and methods for making and using them. These microbeads contain multiple lanthanide nanoparticles and have uniquely identifiable spectral codes, facilitating multiplexing and high-throughput biomarker analysis.

Career Highlights

Throughout her career, Rachel has worked with esteemed organizations such as the University of California and Progenity, Inc. Her experience in these institutions has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Some of her notable coworkers include Brian Cullen Baxter and Joseph L DeRisi. Their collaboration has likely enriched her work and led to innovative solutions in biomedical technology.

Conclusion

Rachel Ellen Gerver is a trailblazer in the realm of biomedical devices, with her patents reflecting her commitment to advancing medical technology. Her contributions are paving the way for future innovations in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…